The Waltham, Mass.-based diagnostics giant plans to offer the notes, due in 2016, to fund its buyout of the Seattle health management firm.
Inverness Medical Innovations Inc. plans to fund its acquisition of Free & Clear with a $100 million offering of senior notes.
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
The FDA approves a novel combat-ready clamp to treat wounds most commonly associated with roadside or...
Vascular Solutions CEO Howard Root says alleged infringement by Boston Scientific's Guidezilla "is...